Clinical Trials Directory

Trials / Completed

CompletedNCT00851019

Dance Dance Revolution (DDR) in Type 2 Diabetes

Dance Dance Revolution (DDR) Exergaming in Adults With Type 2 Diabetes Mellitus

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
76 (actual)
Sponsor
Charles Drew University of Medicine and Science · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Regular physical activity is important for the treatment of type 2 diabetes, but it is often not sustained for many reasons, including lack of interest. New video games that involve physical movement ("exergames") may help in this regard. This study will compare the "exergame" "Dance Dance Revolution" (DDR) with traditional treadmill exercise on blood sugar control among sedentary, overweight or obese adults with type 2 diabetes.

Detailed description

This study is a randomized, controlled trial of a 3-month ad libitum program of the "exergame" "Dance Dance Revolution" (DDR) versus traditional treadmill exercise. Each group of subjects will be assessed at baseline, and then assigned exclusively to one of the two exercise modalities. Subjects will be free to attend exercise sessions in their assigned exercise modality at the exercise facility, at a frequency, duration and intensity of their own choosing with minimal staff supervision, for a period of exactly 90 days; adoption of new exercise programs outside of the study will be prohibited. Dosages of any concurrent medications will be maintained constant, and all subjects will receive standardized nutrition counseling.

Conditions

Interventions

TypeNameDescription
BEHAVIORALDDRAd libitum attendance to engage in "Dance Dance Revolution" (DDR) Exergaming, for a 3-month period
BEHAVIORALTreadmillAd libitum attendance to engage in treadmill exercise, for a 3-month period

Timeline

Start date
2009-02-01
Primary completion
2012-07-01
Completion
2012-07-01
First posted
2009-02-25
Last updated
2013-03-27

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00851019. Inclusion in this directory is not an endorsement.